Vytorin Outcomes Comparison To Zocor Anticipated In 2008, Merck/Schering-Plough Say
This article was originally published in The Pink Sheet Daily
Executive Summary
Following delays in reporting data from ENHANCE, companies narrowed the study’s primary endpoint on the advice of an independent panel.